Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levosimendan vs Milrinone in Septic Cardiomyopathy
NCT02640846Phase 4Unknown
- Sponsor
- Sahlgrenska University Hospital
- Start
- Dec 2015
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan, milrinone in septic cardiomyopathy (SCM), sponsored by Sahlgrenska University Hospital. Status: unknown.
02
Drugs
levosimendanmilrinone
03
Conditions
septic cardiomyopathy (SCM)
Beyond the preview
Go deeper on NCT02640846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02640846.